Parisian computer vision software and surgical robotics technologies company Ganymed Robotics has raised an additional €15 million in a Series B round extension, bringing the total amount of the round to a healthy €36 million.
€14 million has been provided by The European Innovation Council (EIC) Fund, through the EIC Accelerator Program, and Cap Horn Invest (a member of the Anaxago Group), while the ubiquitous Bpifrance provided €1 million in the form of debt financing.
The goals of the new capital mirror those of the company’s initial €21 million Series B announcement last July: completing the development of Ganymed Robotics’ surgical robotic assistant for knee arthroplasty (TKA), accelerating regulatory and market access activities, and helping the company move beyond TKA surgeries via a diversified product offering lineup.
“Welcoming such highly valuable investors a few months after an oversubscribed Series B first close, puts us in an extremely solid position amid a worldwide financing crunch for startups,” commented Ganymed Robotics CEO and co-founder Sophie Cahen. “We now have the resources and expertise to bring our unique patented technology to market, with the aim to become the standard of care for joint replacement.”